...
首页> 外文期刊>Cardiovascular and Interventional Radiology: A Journal of Imaging in Diagnosis and Treatment >Thoracic Endovascular Aortic Repair in 'Shaggy Thoracic Aortic Aneurysms'
【24h】

Thoracic Endovascular Aortic Repair in 'Shaggy Thoracic Aortic Aneurysms'

机译:“毛茸茸的胸主动脉瘤”中的胸腔血管血管系主动脉膜修复

获取原文
获取原文并翻译 | 示例

摘要

Objectives To report the outcomes of thoracic endovascular aortic repair (TEVAR) for shaggy thoracic aortic aneurysms (STA). Methods It is a single center, retrospective, observational, cohort study. Data were collected prospectively between January 2005 and May 2019. STA was defined, based on computed tomography angiography findings, as the presence of an irregular/ulcerated atheroma protruding and/or thrombus thickness >= 5 mm protruding into the aortic lumen, and/or occupying more than two thirds of the circumference of the aortic diameter axially. Primary outcomes were early (<= 30 days) and late survival and freedom from major complication due to end-organ or peripheral ischemic embolization. Results Nine (2.3%) of 391 patients met the inclusion criteria. Mean age was 71 years +/- 10 (range 55-83). Mean aneurysm diameter was 68 mm +/- 0.5 (range 60-75). Four patients presented symptomatic: rupture (n = 2), blue toe syndrome (n = 2). TEVAR was performed in 7 of the 9 patients. Operative-related embolization occurred in 1 patient (transient ischemic attack and acute kidney injury). In-hospital mortality was observed in 1 patient following spinal cord ischemia and multiple organ failure development. Median follow-up was 48 months (IQR 5-84). Freedom from major complication due to end-organ or peripheral ischemic embolization was achieved in all patients. No patient developed further localization of STA in the proximal or distal aorta, and did not experience reno-visceral or peripheral atheroembolization episodes. Conclusions Risk of atheroembolism in STA is still threatening but TEVAR proved to be an effective and durable treatment in this high-risk cohort.
机译:目的报告胸部血管内修复术(TEVAR)治疗粗隆胸主动脉瘤(STA)的疗效。方法采用单中心、回顾性、观察性、队列研究。数据是在2005年1月至2019年5月期间前瞻性收集的。根据计算机断层扫描血管造影结果,STA被定义为存在不规则/溃疡性动脉粥样硬化,突出和/或血栓厚度>=5 mm,突出到主动脉腔,和/或轴向占据主动脉直径周长的三分之二以上。主要转归是早期(<=30天)和晚期生存,以及没有因终末器官或外周缺血栓塞引起的主要并发症。结果391例患者中有9例(2.3%)符合纳入标准。平均年龄为71岁+/-10岁(范围55-83)。平均动脉瘤直径为68mm+/-0.5(范围60-75)。4名患者出现症状:破裂(n=2)、蓝趾综合征(n=2)。9名患者中有7名接受了TEVAR。1例患者发生了与手术相关的栓塞(短暂性脑缺血发作和急性肾损伤)。在脊髓缺血和多器官衰竭发展后,观察到1名患者住院期间死亡。中位随访时间为48个月(IQR 5-84)。所有患者均未出现因终末器官或外周缺血栓塞引起的严重并发症。没有患者出现近端或远端主动脉中STA的进一步定位,也没有出现肾-内脏或外周动脉粥样硬化栓塞事件。结论STA的动脉粥样硬化栓塞风险仍然存在威胁,但TEVAR在这一高危人群中被证明是一种有效且持久的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号